US00437E1029 - Common Stock
ACCOLADE INC
NASDAQ:ACCD (4/19/2024, 10:28:10 AM)
9.25
+0.08 (+0.87%)
Accolade, Inc. engages in the provision of technology-enabled health and benefits solutions. The company is headquartered in Plymouth Meeting, Pennsylvania and currently employs 2,370 full-time employees. The company went IPO on 2020-07-02. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. The company also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.
ACCOLADE INC
660 W. Germantown Pike Suite 500
Plymouth Meeting PENNSYLVANIA 98101
P: 16108342989
CEO: Rajeev Singh
Employees: 2370
Website: https://www.accolade.com
SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor...
The recent Alabama State Supreme Court ruling on frozen embryos could have national repercussions. Here's what you need to know about it.
Progyny (PGNY) and Accolade (ACCD) drop after the Alabama Supreme Court ruled that frozen embryos can be considered children. Read more here.
Here you can normally see the latest stock twits on ACCD, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: